PLRX — Pliant Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $79.87m
- -$111.07m
Annual cashflow statement for Pliant Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -97.3 | -123 | -161 | -210 | -149 |
| Depreciation | |||||
| Non-Cash Items | 13.4 | 22.6 | 41.9 | 43.6 | 35.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.92 | 4.22 | 1.25 | 9.09 | -15.9 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -75.4 | -94.6 | -116 | -156 | -128 |
| Capital Expenditures | -1.95 | -1.76 | -0.921 | -3.85 | -0.374 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 75.7 | -148 | -126 | 144 | 135 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 73.7 | -150 | -127 | 140 | 134 |
| Financing Cash Flow Items | -0.457 | -0.557 | -0.847 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.53 | 227 | 274 | 23.1 | -31.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.783 | -18 | 31 | 7.95 | -25.7 |